BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11389057)

  • 1. Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma.
    Monestiroli S; Mancuso P; Burlini A; Pruneri G; Dell'Agnola C; Gobbi A; Martinelli G; Bertolini F
    Cancer Res; 2001 Jun; 61(11):4341-4. PubMed ID: 11389057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy.
    Patel SA; Nilsson MB; Le X; Cascone T; Jain RK; Heymach JV
    Clin Cancer Res; 2023 Jan; 29(1):30-39. PubMed ID: 35969170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Treatment Combining Antiangiogenesis with Chemoradiotherapy Impinges on the Peripheral Circulation Vascular Endothelial Cells and Therapeutic Effect in the Patients with Locally Advanced Nasopharyngeal Carcinoma.
    Gong X; Wang L; Wu W; Li Y; Long J; Chen X; Luo X; He Q; Bi T; Li Z; Luomeng Y; Jin F
    Biomed Res Int; 2022; 2022():1787854. PubMed ID: 35872851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Endothelial Cell Levels Correlate with Treatment Outcomes of Splanchnic Vein Thrombosis in Patients with Chronic Myeloproliferative Neoplasms.
    Giordano G; Napolitano M; Cellurale M; Di Carlo P; Musuraca G; Micucci G; Lucchesi A
    J Pers Med; 2022 Feb; 12(3):. PubMed ID: 35330364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-endothelial cell antibodies are associated with apoptotic endothelial microparticles, endothelial sloughing and decrease in angiogenic progenitors in systemic sclerosis.
    Michalska-Jakubus MM; Rusek M; Kowal M; Czop M; Kocki J; Krasowska D
    Postepy Dermatol Alergol; 2020 Oct; 37(5):725-735. PubMed ID: 33240013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophil and lymphocyte counts predict bevacizumab response and survival in recurrent glioblastoma.
    Vaios EJ; Winter SF; Muzikansky A; Nahed BV; Dietrich J
    Neurooncol Adv; 2020; 2(1):vdaa031. PubMed ID: 32642690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocytes and Macrophages in Cancer: Unsuspected Roles.
    Gouveia-Fernandes S
    Adv Exp Med Biol; 2020; 1219():161-185. PubMed ID: 32130699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cells in B cell malignancies.
    Yazdani Y; Mohammadnia-Afrouzi M; Yousefi M; Anvari E; Ghalamfarsa G; Hasannia H; Sadreddini S; Jadidi-Niaragh F
    Tumour Biol; 2015 Sep; 36(10):7339-53. PubMed ID: 26330296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer.
    Lee JM; Trepel JB; Choyke P; Cao L; Sissung T; Houston N; Yu M; Figg WD; Turkbey IB; Steinberg SM; Lee MJ; Ivy SP; Liu JF; Matulonis UA; Kohn EC
    Front Oncol; 2015; 5():123. PubMed ID: 26082895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietins in haematopoietic stem cell mobilisation in patients with haematological malignancies.
    Szmigielska-Kaplon A; Krawczynska A; Czemerska M; Pluta A; Cebula-Obrzut B; Szmigielska K; Stępka K; Smolewski P; Robak T; Wierzbowska A
    Blood Transfus; 2015 Jan; 13(1):102-8. PubMed ID: 25369606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy.
    Mehran R; Nilsson M; Khajavi M; Du Z; Cascone T; Wu HK; Cortes A; Xu L; Zurita A; Schier R; Riedel B; El-Zein R; Heymach JV
    Cancer Res; 2014 May; 74(10):2731-41. PubMed ID: 24626092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy-induced hypertension is accompanied by decreased number of circulating endothelial cells and circulating endothelial progenitor cells.
    Heimrath J; Paprocka M; Czekanski A; Ledwozyw A; Kantor A; Dus D
    Arch Immunol Ther Exp (Warsz); 2014 Aug; 62(4):353-6. PubMed ID: 24563102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer.
    Ilie M; Long E; Hofman V; Selva E; Bonnetaud C; Boyer J; Vénissac N; Sanfiorenzo C; Ferrua B; Marquette CH; Mouroux J; Hofman P
    Br J Cancer; 2014 Mar; 110(5):1236-43. PubMed ID: 24473396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of angiogenesis in human non-Hodgkin lymphomas.
    Ribatti D; Nico B; Ranieri G; Specchia G; Vacca A
    Neoplasia; 2013 Mar; 15(3):231-8. PubMed ID: 23479502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study.
    Schilder RJ; Sill MW; Lankes HA; Gold MA; Mannel RS; Modesitt SC; Hanjani P; Bonebrake AJ; Sood AK; Godwin AK; Hu W; Alpaugh RK
    Gynecol Oncol; 2013 Apr; 129(1):86-91. PubMed ID: 23321064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomy.
    Wong CK; Namdarian B; Chua J; Chin X; Speirs R; Nguyen T; Fankhauser M; Pedersen J; Costello AJ; Corcoran NM; Hovens CM
    Br J Cancer; 2012 Oct; 107(9):1564-73. PubMed ID: 23047552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating endothelial progenitor cells in metronomic chemotherapy using irinotecan and/or bevacizumab for colon carcinoma: Study of their clinical significance.
    Murakami H; Ogata Y; Akagi Y; Ishibashi N; Shirouzu K
    Exp Ther Med; 2011 Jul; 2(4):595-600. PubMed ID: 22977546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent.
    Shin SJ; Hwang JW; Ahn JB; Rha SY; Roh JK; Chung HC
    Invest New Drugs; 2013 Feb; 31(1):1-13. PubMed ID: 22539090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microenvironment-centred dynamics in aggressive B-cell lymphomas.
    Cacciatore M; Guarnotta C; Calvaruso M; Sangaletti S; Florena AM; Franco V; Colombo MP; Tripodo C
    Adv Hematol; 2012; 2012():138079. PubMed ID: 22400028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomimetic postcapillary expansions for enhancing rare blood cell separation on a microfluidic chip.
    Jain A; Munn LL
    Lab Chip; 2011 Sep; 11(17):2941-7. PubMed ID: 21773633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.